Onset and frequency of depression in post-COVID-19 syndrome: A systematic review

Following recovery from COVID-19, an increasing proportion of individuals have reported the persistence and/or new onset of symptoms which collectively have been identified as post-COVID-19 syndrome by the National Institute for Health and Care Excellence. Although depressive symptoms in the acute p...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of psychiatric research Ročník 144; s. 129 - 137
Hlavní autori: Renaud-Charest, Olivier, Lui, Leanna M.W., Eskander, Sherry, Ceban, Felicia, Ho, Roger, Di Vincenzo, Joshua D., Rosenblat, Joshua D., Lee, Yena, Subramaniapillai, Mehala, McIntyre, Roger S.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Elsevier Ltd 01.12.2021
Predmet:
ISSN:0022-3956, 1879-1379, 1879-1379
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Following recovery from COVID-19, an increasing proportion of individuals have reported the persistence and/or new onset of symptoms which collectively have been identified as post-COVID-19 syndrome by the National Institute for Health and Care Excellence. Although depressive symptoms in the acute phase of COVID-19 have been well characterized, the frequency of depression following recovery of the acute phase remains unknown. Herein, we sought to determine the frequency of depressive symptoms and clinically-significant depression more than 12 weeks following SARS-CoV-2 infection. A systematic search of PubMed, Ovid Medline and Google Scholar for studies published between January 1, 2020 and June 5, 2021 was conducted. Frequency and factors associated with depression in post-COVID-19 syndrome were recorded and qualitatively assessed through narrative synthesis. Methodological quality and risk of bias was assessed using a modified version of the Newcastle-Ottawa Scale (NOS) for prospective cohort studies. Of 316 articles identified through our systematic search, eight studies were included. The frequency of depressive symptoms +12 weeks following SARS-CoV-2 infection ranged from 11 to 28%. The frequency of clinically-significant depression and/or severe depressive symptoms ranged from 3 to 12%. The severity of acute COVID-19 was not associated with the frequency of depressive symptoms. However, the component studies were highly heterogeneous with respect to mode of ascertainment, time of assessment, and location and age of patients. The majority of studies did not include an unexposed control group. Future research should endeavour to produce a standardized classification of post-COVID-19 syndrome, and as well as include unexposed control groups.
AbstractList Following recovery from COVID-19, an increasing proportion of individuals have reported the persistence and/or new onset of symptoms which collectively have been identified as post-COVID-19 syndrome by the National Institute for Health and Care Excellence. Although depressive symptoms in the acute phase of COVID-19 have been well characterized, the frequency of depression following recovery of the acute phase remains unknown. Herein, we sought to determine the frequency of depressive symptoms and clinically-significant depression more than 12 weeks following SARS-CoV-2 infection. A systematic search of PubMed, Ovid Medline and Google Scholar for studies published between January 1, 2020 and June 5, 2021 was conducted. Frequency and factors associated with depression in post-COVID-19 syndrome were recorded and qualitatively assessed through narrative synthesis. Methodological quality and risk of bias was assessed using a modified version of the Newcastle-Ottawa Scale (NOS) for prospective cohort studies. Of 316 articles identified through our systematic search, eight studies were included. The frequency of depressive symptoms +12 weeks following SARS-CoV-2 infection ranged from 11 to 28%. The frequency of clinically-significant depression and/or severe depressive symptoms ranged from 3 to 12%. The severity of acute COVID-19 was not associated with the frequency of depressive symptoms. However, the component studies were highly heterogeneous with respect to mode of ascertainment, time of assessment, and location and age of patients. The majority of studies did not include an unexposed control group. Future research should endeavour to produce a standardized classification of post-COVID-19 syndrome, and as well as include unexposed control groups.
Following recovery from COVID-19, an increasing proportion of individuals have reported the persistence and/or new onset of symptoms which collectively have been identified as post-COVID-19 syndrome by the National Institute for Health and Care Excellence. Although depressive symptoms in the acute phase of COVID-19 have been well characterized, the frequency of depression following recovery of the acute phase remains unknown. Herein, we sought to determine the frequency of depressive symptoms and clinically-significant depression more than 12 weeks following SARS-CoV-2 infection. A systematic search of PubMed, Ovid Medline and Google Scholar for studies published between January 1, 2020 and June 5, 2021 was conducted. Frequency and factors associated with depression in post-COVID-19 syndrome were recorded and qualitatively assessed through narrative synthesis. Methodological quality and risk of bias was assessed using a modified version of the Newcastle-Ottawa Scale (NOS) for prospective cohort studies. Of 316 articles identified through our systematic search, eight studies were included. The frequency of depressive symptoms +12 weeks following SARS-CoV-2 infection ranged from 11 to 28%. The frequency of clinically-significant depression and/or severe depressive symptoms ranged from 3 to 12%. The severity of acute COVID-19 was not associated with the frequency of depressive symptoms. However, the component studies were highly heterogeneous with respect to mode of ascertainment, time of assessment, and location and age of patients. The majority of studies did not include an unexposed control group. Future research should endeavour to produce a standardized classification of post-COVID-19 syndrome, and as well as include unexposed control groups.Following recovery from COVID-19, an increasing proportion of individuals have reported the persistence and/or new onset of symptoms which collectively have been identified as post-COVID-19 syndrome by the National Institute for Health and Care Excellence. Although depressive symptoms in the acute phase of COVID-19 have been well characterized, the frequency of depression following recovery of the acute phase remains unknown. Herein, we sought to determine the frequency of depressive symptoms and clinically-significant depression more than 12 weeks following SARS-CoV-2 infection. A systematic search of PubMed, Ovid Medline and Google Scholar for studies published between January 1, 2020 and June 5, 2021 was conducted. Frequency and factors associated with depression in post-COVID-19 syndrome were recorded and qualitatively assessed through narrative synthesis. Methodological quality and risk of bias was assessed using a modified version of the Newcastle-Ottawa Scale (NOS) for prospective cohort studies. Of 316 articles identified through our systematic search, eight studies were included. The frequency of depressive symptoms +12 weeks following SARS-CoV-2 infection ranged from 11 to 28%. The frequency of clinically-significant depression and/or severe depressive symptoms ranged from 3 to 12%. The severity of acute COVID-19 was not associated with the frequency of depressive symptoms. However, the component studies were highly heterogeneous with respect to mode of ascertainment, time of assessment, and location and age of patients. The majority of studies did not include an unexposed control group. Future research should endeavour to produce a standardized classification of post-COVID-19 syndrome, and as well as include unexposed control groups.
Author Ceban, Felicia
Lee, Yena
Subramaniapillai, Mehala
Renaud-Charest, Olivier
Lui, Leanna M.W.
McIntyre, Roger S.
Eskander, Sherry
Ho, Roger
Di Vincenzo, Joshua D.
Rosenblat, Joshua D.
Author_xml – sequence: 1
  givenname: Olivier
  surname: Renaud-Charest
  fullname: Renaud-Charest, Olivier
  organization: Mood Disorder Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
– sequence: 2
  givenname: Leanna M.W.
  surname: Lui
  fullname: Lui, Leanna M.W.
  organization: Mood Disorder Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
– sequence: 3
  givenname: Sherry
  orcidid: 0000-0002-9818-0753
  surname: Eskander
  fullname: Eskander, Sherry
  organization: Mood Disorder Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
– sequence: 4
  givenname: Felicia
  orcidid: 0000-0001-6815-7248
  surname: Ceban
  fullname: Ceban, Felicia
  organization: Mood Disorder Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
– sequence: 5
  givenname: Roger
  surname: Ho
  fullname: Ho, Roger
  organization: Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
– sequence: 6
  givenname: Joshua D.
  surname: Di Vincenzo
  fullname: Di Vincenzo, Joshua D.
  organization: Mood Disorder Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
– sequence: 7
  givenname: Joshua D.
  surname: Rosenblat
  fullname: Rosenblat, Joshua D.
  organization: Mood Disorder Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
– sequence: 8
  givenname: Yena
  surname: Lee
  fullname: Lee, Yena
  organization: Mood Disorder Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
– sequence: 9
  givenname: Mehala
  surname: Subramaniapillai
  fullname: Subramaniapillai, Mehala
  organization: Mood Disorder Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
– sequence: 10
  givenname: Roger S.
  orcidid: 0000-0003-4733-2523
  surname: McIntyre
  fullname: McIntyre, Roger S.
  email: roger.mcintyre@uhn.ca
  organization: Mood Disorder Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34619491$$D View this record in MEDLINE/PubMed
BookMark eNqNkU1v1DAQhi1URLeFv4By5JJgO86HOSDaBdpKlZZDxdVyxhPqJbGDnS3Kv8erthR62pMteeZ5x_OckCPnHRKSMVowyur322I7xQVubcBYcMpZQWVBK_GCrFjbyJyVjTwiK0o5z0tZ1cfkJMYtpbThTLwix6WomRSSrci3jYs4Z9qZrA_4a4cOlsz3mcEpsaP1LrMum3yc8_Xm-9XnnMksLs4EP-KH7Czd44yjni1kAe8s_n5NXvZ6iPjm4TwlN1-_3Kwv8-vNxdX67DqHqqznvBfcsJZxVusWGxB91wB0rO07QRtEXRuomx4YlwBNTysOHdemN9iUpRBQnpKP99hp141oAN0c9KCmYEcdFuW1Vf-_OHurfvg71YqWt4ImwLsHQPDp23FWo42Aw6Ad-l1UvGppLVkt61T69t-svyGPW3waBoKPMWCvwM5pJ34fbQfFqNprU1v1pE3ttSkqVdKWAO0zwGPGAa3n962Ylp0EBBXBJotoUinMynh7COTTMwgM1lnQw09cDkP8AWVE0VU
CitedBy_id crossref_primary_10_1016_j_idh_2022_04_003
crossref_primary_10_3390_ijerph21040473
crossref_primary_10_3390_vaccines11071139
crossref_primary_10_1080_14737175_2024_2333394
crossref_primary_10_1080_13548506_2023_2177684
crossref_primary_10_3390_jcm12020420
crossref_primary_10_51847_ugVSTNJDMP
crossref_primary_10_1016_j_psychres_2023_115166
crossref_primary_10_1038_s41598_023_39209_z
crossref_primary_10_3390_healthcare11182477
crossref_primary_10_3389_fpsyg_2024_1407887
crossref_primary_10_1055_a_1946_3230
crossref_primary_10_4103_indianjpsychiatry_indianjpsychiatry_105_23
crossref_primary_10_1038_s41398_024_02831_0
crossref_primary_10_47102_annals_acadmedsg_202341
crossref_primary_10_1016_j_carrev_2024_06_008
crossref_primary_10_1016_j_mayocpiqo_2024_09_004
crossref_primary_10_1016_j_imu_2022_100976
crossref_primary_10_3389_fpsyt_2023_1107560
crossref_primary_10_1016_j_reprotox_2024_108755
crossref_primary_10_3389_fpsyt_2023_1239583
crossref_primary_10_1007_s44192_022_00027_w
crossref_primary_10_1177_23743735241272267
crossref_primary_10_1134_S1819712424700508
crossref_primary_10_1177_18344909231208906
crossref_primary_10_1016_j_jpsychires_2023_12_005
crossref_primary_10_3389_fpsyt_2023_1257553
crossref_primary_10_1016_j_glohj_2022_02_001
crossref_primary_10_3390_v16030320
crossref_primary_10_1080_22221751_2023_2204166
crossref_primary_10_2196_44155
crossref_primary_10_1093_biomtc_ujaf021
crossref_primary_10_1007_s40211_023_00487_8
crossref_primary_10_1590_0102_311xen027423
crossref_primary_10_1016_j_vhri_2024_101039
crossref_primary_10_1155_2024_6530028
crossref_primary_10_1080_07448481_2022_2068958
crossref_primary_10_1186_s12888_025_07172_w
crossref_primary_10_3389_fpsyt_2023_1269402
crossref_primary_10_1016_j_psychres_2022_114924
crossref_primary_10_1002_jmv_29725
crossref_primary_10_1093_pubmed_fdad276
crossref_primary_10_1016_j_clinph_2022_10_017
crossref_primary_10_2147_IDR_S386566
crossref_primary_10_1093_gastro_goae069
crossref_primary_10_1109_ACCESS_2024_3366653
crossref_primary_10_1038_s41598_024_60437_4
crossref_primary_10_1080_03007995_2024_2360647
crossref_primary_10_3390_ijms242015254
crossref_primary_10_1017_ipm_2023_53
crossref_primary_10_3389_fmed_2024_1288761
crossref_primary_10_3389_fpsyg_2025_1440054
crossref_primary_10_3390_jcm11206060
crossref_primary_10_1016_j_bbih_2023_100587
crossref_primary_10_3390_vaccines11010194
crossref_primary_10_3390_vaccines10070989
crossref_primary_10_1016_j_jece_2022_109012
crossref_primary_10_1371_journal_pone_0286371
crossref_primary_10_3389_fpsyg_2023_1116566
crossref_primary_10_3389_fpsyt_2023_1100355
crossref_primary_10_1007_s00406_024_01868_y
crossref_primary_10_1002_lary_30122
crossref_primary_10_1080_09515089_2022_2147422
crossref_primary_10_3389_fneur_2024_1486751
crossref_primary_10_1016_j_pcd_2023_05_006
crossref_primary_10_1016_j_ejpsy_2022_09_007
crossref_primary_10_1016_j_pnpbp_2024_110993
crossref_primary_10_1177_21501319251334207
crossref_primary_10_1007_s11606_024_09062_5
crossref_primary_10_1016_j_optmat_2023_114541
crossref_primary_10_3390_jcm11144104
crossref_primary_10_1186_s43045_024_00487_6
crossref_primary_10_1016_j_euroneuro_2025_02_009
crossref_primary_10_1177_19345798251354969
crossref_primary_10_1016_j_jad_2022_11_065
crossref_primary_10_1016_j_heliyon_2022_e09729
crossref_primary_10_1016_j_jad_2022_11_068
crossref_primary_10_1016_j_ajp_2022_103438
crossref_primary_10_1038_s41598_022_17077_3
crossref_primary_10_1109_TBCAS_2023_3292237
crossref_primary_10_1146_annurev_med_043021_030635
crossref_primary_10_1111_jnu_12967
crossref_primary_10_1007_s00406_023_01617_7
crossref_primary_10_1177_23743735241252475
crossref_primary_10_1371_journal_pone_0289382
crossref_primary_10_1016_j_imu_2022_100936
crossref_primary_10_2147_PRBM_S371787
crossref_primary_10_1016_j_heliyon_2022_e10142
crossref_primary_10_3389_fneur_2024_1426881
crossref_primary_10_3390_jcm13051442
crossref_primary_10_1016_j_bbih_2025_100954
crossref_primary_10_1016_j_outlook_2024_102341
crossref_primary_10_3389_fpsyt_2023_1218298
crossref_primary_10_3233_JAD_221271
crossref_primary_10_2147_HMER_S384070
crossref_primary_10_1016_j_jad_2025_05_018
crossref_primary_10_1111_ijn_13202
crossref_primary_10_3390_jpm13030503
crossref_primary_10_1038_s41598_023_37426_0
crossref_primary_10_1007_s12144_022_03782_9
crossref_primary_10_1186_s12955_024_02245_y
crossref_primary_10_1016_j_jmh_2023_100185
crossref_primary_10_1016_j_jad_2022_11_044
crossref_primary_10_2147_PRBM_S360455
crossref_primary_10_1007_s12144_022_03207_7
crossref_primary_10_1371_journal_pone_0302543
crossref_primary_10_1007_s11065_024_09642_6
crossref_primary_10_1007_s44192_025_00193_7
crossref_primary_10_1186_s12888_023_05358_8
crossref_primary_10_3390_ejihpe14010015
crossref_primary_10_1002_brx2_72
crossref_primary_10_1093_ofid_ofad320
crossref_primary_10_3390_jcm12020511
crossref_primary_10_3892_etm_2022_11290
crossref_primary_10_1016_j_imu_2022_100962
crossref_primary_10_1016_j_trim_2023_101883
crossref_primary_10_1515_tnsci_2022_0360
crossref_primary_10_4103_jspf_JSPF_5_23
crossref_primary_10_3390_ijerph20166575
crossref_primary_10_1016_j_cegh_2022_101209
crossref_primary_10_1080_03007995_2024_2374510
crossref_primary_10_14309_ctg_0000000000000524
crossref_primary_10_1016_j_bspc_2024_106051
crossref_primary_10_3390_pharmaceutics14091906
crossref_primary_10_1080_09540261_2021_2011709
crossref_primary_10_3390_biomedicines11020550
crossref_primary_10_1016_j_bbi_2021_12_020
crossref_primary_10_1016_j_jad_2022_08_120
crossref_primary_10_1007_s11606_024_08630_z
crossref_primary_10_3390_ijerph20010339
crossref_primary_10_1016_j_jad_2022_12_100
crossref_primary_10_1016_j_jad_2023_08_080
crossref_primary_10_3389_fpubh_2024_1282067
crossref_primary_10_1007_s12144_023_04500_9
crossref_primary_10_1177_00469580221138671
crossref_primary_10_3390_pharmaceutics17030355
crossref_primary_10_1016_j_jad_2022_09_040
crossref_primary_10_3389_fpubh_2022_937100
crossref_primary_10_1007_s12144_022_03148_1
crossref_primary_10_3390_ijerph19169924
crossref_primary_10_3390_cells13171436
crossref_primary_10_1186_s40249_023_01074_3
crossref_primary_10_1002_jmv_28236
crossref_primary_10_1007_s10787_023_01380_0
crossref_primary_10_3390_life13020508
crossref_primary_10_1016_j_euroecorev_2023_104621
crossref_primary_10_1080_09603123_2024_2375350
crossref_primary_10_3390_ijerph19126963
crossref_primary_10_1016_j_rpsm_2022_05_008
crossref_primary_10_1590_0102_311xpt027423
crossref_primary_10_36660_abc_20220642
crossref_primary_10_3357_AMHP_6202_2023
crossref_primary_10_1016_j_psychres_2023_115301
crossref_primary_10_1038_s43856_024_00440_y
crossref_primary_10_3390_ijerph19063742
crossref_primary_10_1007_s11682_022_00739_1
crossref_primary_10_1016_j_psychres_2023_115414
crossref_primary_10_3390_ijerph20064889
crossref_primary_10_3390_brainsci13040688
crossref_primary_10_3390_ijerph192215327
crossref_primary_10_1016_j_jpsychires_2022_10_045
crossref_primary_10_1038_s41598_023_42350_4
crossref_primary_10_3390_ijerph22081249
crossref_primary_10_1016_j_jad_2022_09_062
crossref_primary_10_1002_pcn5_70017
crossref_primary_10_3390_jcm11030524
crossref_primary_10_1016_j_apgeog_2024_103397
crossref_primary_10_1016_j_jpsychires_2025_06_033
crossref_primary_10_1016_j_jpsychores_2023_111230
crossref_primary_10_56936_18291775_2023_36_53
crossref_primary_10_1007_s10787_022_01062_3
crossref_primary_10_1186_s12913_023_09601_6
crossref_primary_10_1017_neu_2022_21
crossref_primary_10_1016_j_jpsychores_2023_111475
crossref_primary_10_1097_MD_0000000000042444
crossref_primary_10_1089_jwh_2022_0115
crossref_primary_10_1016_j_tmaid_2023_102606
crossref_primary_10_1176_appi_neuropsych_20230121
crossref_primary_10_1177_10815589241261291
crossref_primary_10_1007_s41811_025_00265_0
crossref_primary_10_1177_26331055231186998
crossref_primary_10_1038_s41598_022_25297_w
crossref_primary_10_1016_j_ijpharm_2025_126173
crossref_primary_10_1016_j_psc_2022_07_007
crossref_primary_10_1016_j_pmr_2023_04_006
crossref_primary_10_3389_fnins_2023_1249282
crossref_primary_10_1128_spectrum_04651_22
crossref_primary_10_1016_j_neulet_2022_136922
crossref_primary_10_1038_s41598_022_17110_5
crossref_primary_10_1017_neu_2024_10
crossref_primary_10_1016_j_carbpol_2024_122527
crossref_primary_10_1111_psyg_13057
crossref_primary_10_1016_j_bbi_2023_03_022
crossref_primary_10_1016_j_jad_2024_08_214
crossref_primary_10_1007_s10892_023_09437_6
crossref_primary_10_1192_j_eurpsy_2023_2418
crossref_primary_10_2147_NDT_S427957
crossref_primary_10_1016_j_cegh_2023_101250
crossref_primary_10_1002_acn3_51952
crossref_primary_10_1186_s13041_023_01040_y
crossref_primary_10_1177_20499361231198335
crossref_primary_10_1017_S0033291723002313
crossref_primary_10_7769_gesec_v14i7_2485
crossref_primary_10_1016_j_psychres_2024_116068
crossref_primary_10_1007_s10942_023_00519_w
crossref_primary_10_3390_ijerph191710464
crossref_primary_10_1016_j_euroneuro_2023_02_006
crossref_primary_10_1016_j_jad_2025_119525
crossref_primary_10_1371_journal_pone_0284766
crossref_primary_10_1371_journal_pone_0315425
crossref_primary_10_3389_fpsyg_2024_1378213
crossref_primary_10_1177_02537176221140557
crossref_primary_10_1186_s13690_025_01509_3
crossref_primary_10_1371_journal_pone_0279624
crossref_primary_10_12998_wjcc_v12_i15_2560
crossref_primary_10_1136_bmjph_2024_001112
crossref_primary_10_1016_j_rpsm_2022_04_004
crossref_primary_10_3390_ijerph191610362
crossref_primary_10_1016_j_bbih_2022_100491
crossref_primary_10_1016_j_jad_2024_02_041
crossref_primary_10_1109_TNSRE_2023_3320693
crossref_primary_10_1111_pcn_13508
crossref_primary_10_3389_fimmu_2023_1181973
crossref_primary_10_3390_a17110485
crossref_primary_10_1002_ijgo_15416
crossref_primary_10_1016_j_heliyon_2022_e10415
crossref_primary_10_1016_j_jsps_2022_05_004
crossref_primary_10_1007_s12671_023_02234_0
crossref_primary_10_1016_j_dscb_2025_100228
crossref_primary_10_1136_bmjopen_2022_071169
crossref_primary_10_1016_j_jiph_2024_05_052
crossref_primary_10_1186_s12905_023_02283_6
crossref_primary_10_1038_s41598_024_60368_0
crossref_primary_10_1177_25424823251328627
Cites_doi 10.1038/s41598-018-30487-6
10.3109/09540261.2010.492391
10.3390/ijerph18105363
10.1016/j.bbi.2021.02.021
10.1038/s41586-020-2787-6
10.1038/s41591-021-01283-z
10.1001/jamaneurol.2020.2065
10.1186/1741-7015-11-200
10.1080/22221751.2020.1770129
10.1016/S0140-6736(17)32154-2
10.1016/j.jpsychores.2021.110525
10.1016/j.bbi.2020.04.027
10.18632/aging.103344
10.1371/journal.pmed.1003583
10.1016/S2215-0366(21)00084-5
10.1038/s41398-020-0696-y
10.3109/02813432.2011.554009
10.1001/jama.2021.3331
10.3389/fpsyt.2021.655211
10.1016/j.jpsychires.2020.10.015
10.1016/j.chest.2021.02.062
10.1016/j.jad.2020.08.001
10.1016/j.jns.2021.117486
10.1016/j.jaac.2020.05.009
10.1016/j.ijid.2020.05.055
10.1016/j.jad.2011.08.003
10.47102/annals-acadmedsg.202043
10.1016/j.jad.2021.04.050
10.1097/YCO.0000000000000713
10.3389/fimmu.2020.01446
10.3390/ijerph18115861
10.1371/journal.pone.0186700
10.1016/j.pnpbp.2014.01.013
10.1001/jamanetworkopen.2020.19686
10.1038/s41598-021-85943-7
10.1016/j.psychres.2020.112934
10.1007/s12603-020-1500-7
10.1111/ene.14803
10.3389/fimmu.2019.01696
10.1001/jamanetworkopen.2021.11417
10.1016/j.jpsychores.2020.110186
10.1056/NEJMra2026131
10.1007/s00415-021-10579-6
10.1016/j.bbi.2020.07.037
ContentType Journal Article
Copyright 2021 Elsevier Ltd
Copyright © 2021 Elsevier Ltd. All rights reserved.
2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd
Copyright_xml – notice: 2021 Elsevier Ltd
– notice: Copyright © 2021 Elsevier Ltd. All rights reserved.
– notice: 2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.jpsychires.2021.09.054
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1379
EndPage 137
ExternalDocumentID PMC8482840
34619491
10_1016_j_jpsychires_2021_09_054
S002239562100594X
Genre Systematic Review
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29L
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
9JO
AABNK
AADFP
AAEDT
AAEDW
AAGJA
AAGUQ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABIVO
ABJNI
ABLJU
ABMAC
ABMZM
ABOYX
ABPPZ
ABWVN
ABXDB
ACDAQ
ACGFS
ACHQT
ACIEU
ACIUM
ACLOT
ACNCT
ACRLP
ACRPL
ACVFH
ACXNI
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADXHL
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEG
HF~
HMK
HMO
HMQ
HMW
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M29
M2V
M39
M3V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OH0
OKEIE
OU-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SPS
SSB
SSH
SSN
SSY
SSZ
T5K
WUQ
YQT
Z5R
ZGI
~G-
~HD
AACTN
AADPK
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AFYLN
AJBFU
AJOXV
AMFUW
LCYCR
RIG
ZA5
9DU
AAYXX
CITATION
AGCQF
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c536t-f42d181216a8e7c4fb7ccb18fb407eea6dc67fc129cc7f052cb2adfde73344c3
ISICitedReferencesCount 256
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000707671500017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0022-3956
1879-1379
IngestDate Tue Sep 30 16:48:09 EDT 2025
Sat Sep 27 22:31:24 EDT 2025
Mon Jul 21 06:06:22 EDT 2025
Tue Nov 18 20:53:09 EST 2025
Sat Nov 29 07:28:12 EST 2025
Fri Feb 23 02:39:41 EST 2024
Tue Oct 14 19:36:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords COVID-19
Depression
SARS-CoV-2
Post-acute sequelae of COVID-19
Post-COVID-19 syndrome
Population health
Language English
License Copyright © 2021 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c536t-f42d181216a8e7c4fb7ccb18fb407eea6dc67fc129cc7f052cb2adfde73344c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
ORCID 0000-0003-4733-2523
0000-0001-6815-7248
0000-0002-9818-0753
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8482840
PMID 34619491
PQID 2580691696
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8482840
proquest_miscellaneous_2580691696
pubmed_primary_34619491
crossref_citationtrail_10_1016_j_jpsychires_2021_09_054
crossref_primary_10_1016_j_jpsychires_2021_09_054
elsevier_sciencedirect_doi_10_1016_j_jpsychires_2021_09_054
elsevier_clinicalkey_doi_10_1016_j_jpsychires_2021_09_054
PublicationCentury 2000
PublicationDate 2021-12-01
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of psychiatric research
PublicationTitleAlternate J Psychiatr Res
PublicationYear 2021
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References (bib14) 2017; 390
Lee, Giuliani (bib15) 2019; 10
Mattioli, Stampatori, Righetti, Sala, Tomasi, De Palma (bib21) 2021
Wells, Shea, O'Connell, Robertson, Peterson, Welch, Losos, Tugwell (bib46) 2000
(bib47) 2021
Cao, Fang, Hou, Han, Xu, Dong, Zheng (bib3) 2020; 287
Frontera, Yang, Lewis, Patel, Medicherla, Arena, Fang, Andino, Snyder, Madhavan, Gratch, Fuchs, Dessy, Canizares, Jauregui, Thomas, Bauman, Olivera, Bhagat, Sonson, Park, Stainman, Sunwoo, Talmasov, Tamimi, Zhu, Rosenthal, Dygert, Ristic, Ishii, Valdes, Omari, Gurin, Huang, Czeisler, Kahn, Zhou, Lin, Lord, Melmed, Meropol, Troxel, Petkova, Wisniewski, Balcer, Morrison, Yaghi, Galetta (bib9) 2021; 426
Ragab, Salah Eldin, Taeimah, Khattab, Salem (bib34) 2020; 11
Pieh, Budimir, Probst (bib33) 2020; 136
Xiong, Lipsitz, Nasri, Lui, Gill, Phan, Chen-Li, Iacobucci, Ho, Majeed, McIntyre (bib48) 2020; 277
van den Borst, Peters, Brink, Schoon, Bleeker-Rovers, Schers, van Hees, van Helvoort, van den Boogaard, van der Hoeven, Reijers, Prokop, Vercoulen, van den Heuvel (bib43) 2020
Troyer, Kohn, Hong (bib42) 2020; 87
Daher, Cornelissen, Hartmann, Balfanz, Müller, Bergs, Aetou, Marx, Marx, Simon, Müller-Wieland, Hartmann, Kersten, Müller, Dreher (bib6) 2021; 18
Sinanović (bib39) 2021; 33
Liu, Baumeister, Zhou (bib18) 2021; 137
Vanderlind, Rabinovitz, Miao, Oberlin, Bueno-Castellano, Fridman, Jaywant, Kanellopoulos (bib44) 2021; 34
Lee, Lui, Chen-Li, Liao, Mansur, Brietzke, Rosenblat, Ho, Rodrigues, Lipsitz, Nasri, Cao, Subramaniapillai, Gill, Lu, McIntyre (bib16) 2021; 290
Ho, Chee, Ho (bib12) 2020; 49
Mueller, McNamara, Sinclair (bib25) 2020; 12
Nalbandian, Sehgal, Gupta, Madhavan, McGroder, Stevens, Cook, Nordvig, Shalev, Sehrawat, Ahluwalia, Bikdeli, Dietz, Der-Nigoghossian, Liyanage-Don, Rosner, Bernstein, Mohan, Beckley, Seres, Choueiri, Uriel, Ausiello, Accili, Freedberg, Baldwin, Schwartz, Brodie, Garcia, Elkind, Connors, Bilezikian, Landry, Wan (bib27) 2021; 27
Parker, Brotchie (bib32) 2010; 22
Morin, Savale, Pham, Colle, Figueiredo, Harrois, Gasnier, Lecoq, Meyrignac, Noel, Baudry, Bellin, Beurnier, Choucha, Corruble, Dortet, Hardy-Leger, Radiguer, Sportouch, Verny, Wyplosz, Zaidan, Becquemont, Montani, Monnet (bib24) 2021; 325
Fajgenbaum, June (bib8) 2020; 383
Huang, Pinto, Borelli, Mehrabadi, Abrihim, Dutt, Lambert, Nurmi, Chakraborty, Rahmani, Downs (bib13) 2021
Muñoz-Fontela, Dowling, Funnell, Gsell, Riveros-Balta, Albrecht, Andersen, Baric, Carroll, Cavaleri, Qin, Crozier, Dallmeier, de Waal, de Wit, Delang, Dohm, Duprex, Falzarano, Finch, Frieman, Graham, Gralinski, Guilfoyle, Haagmans, Hamilton, Hartman, Herfst, Kaptein, Klimstra, Knezevic, Krause, Kuhn, Le Grand, Lewis, Liu, Maisonnasse, McElroy, Munster, Oreshkova, Rasmussen, Rocha-Pereira, Rockx, Rodríguez, Rogers, Salguero, Schotsaert, Stittelaar, Thibaut, Tseng, Vergara-Alert, Beer, Brasel, Chan, García-Sastre, Neyts, Perlman, Reed, Richt, Roy, Segalés, Vasan, Henao-Restrepo, Barouch (bib26) 2020; 586
Sepúlveda-Loyola, Rodríguez-Sánchez, Pérez-Rodríguez, Ganz, Torralba, Oliveira, Rodríguez-Mañas (bib37) 2020; 24
Han, Ma, Li, Liu, Zhao, Wang, Zhang, Liu, Gao, Liu, Jiang, Cheng, Zhu, Xia (bib11) 2020; 9
Loades, Chatburn, Higson-Sweeney, Reynolds, Shafran, Brigden, Linney, McManus, Borwick, Crawley (bib19) 2020; 59
Mazza, De Lorenzo, Conte, Poletti, Vai, Bollettini, Melloni, Furlan, Ciceri, Rovere-Querini (bib22) 2020; 89
Zubair, McAlpine, Gardin, Farhadian, Kuruvilla, Spudich (bib50) 2020; 77
Berk, Williams, Jacka, O'Neil, Pasco, Moylan, Allen, Stuart, Hayley, Byrne, Maes (bib2) 2013; 11
Nasserie, Hittle, Goodman (bib28) 2021; 4
Ettman, Abdalla, Cohen, Sampson, Vivier, Galea (bib7) 2020; 3
Lu, Ho, Liu, Chua, Wang, McIntyre, Ho (bib20) 2017; 12
Szlamka, Kiss, Bernáth, Kámán, Lubani, Karner, Demetrovics (bib40) 2021; 12
(bib1) 2021
Christensen, Sokolowski, Olesen (bib5) 2011; 29
Ng, Tam, Zhang, Ho, Husain, McIntyre, Ho (bib29) 2018
Shanbehzadeh, Tavahomi, Zanjari, Ebrahimi-Takamjani, Amiri-Arimi (bib38) 2021; 147
Rosenblat, Cha, Mansur, McIntyre (bib36) 2014; 53
Wang, Chudzicka-Czupała, Tee, Núñez, Tripp, Fardin, Habib, Tran, Adamus, Anlacan, García, Grabowski, Hussain, Hoang, Hetnał, Le, Ma, Pham, Reyes, Shirazi, Tan, Tee, Xu, Xu, Vu, Zhou, Chan, Kuruchittham, McIntyre, Ho, Ho, Sears (bib45) 2021; 11
Taquet, Geddes, Husain, Luciano, Harrison (bib41) 2021; 8
Rass, Beer, Schiefecker, Kofler, Lindner, Mahlknecht, Heim, Limmert, Sahanic, Pizzini, Sonnweber, Tancevski, Scherfler, Zamarian, Bellmann-Weiler, Weiss, Djamshidian, Kiechl, Seppi, Loeffler-Ragg, Pfausler, Helbok (bib35) 2021
Mazza, Palladini, De Lorenzo, Magnaghi, Poletti, Furlan, Ciceri, Rovere-Querini, Benedetti (bib23) 2021; 94
Liu, Ho, Mak (bib17) 2012
Ng, Fam, Feng, Cheah, Tan, Nur, Wee, Goh, Chow, Ho, Kua, Larbi, Mahendran (bib30) 2020; 10
González, Benítez, Carmona, Santisteve, Monge, Moncusí-Moix, Gort-Paniello, Pinilla, Carratalá, Zuil, Ferrer, Ceccato, Fernández, Motos, Riera, Menéndez, Garcia-Gasulla, Peñuelas, Bermejo-Martin, Labarca, Caballero, Torres, de Gonzalo-Calvo, Torres, Barbé (bib10) 2021
Zeng, Huang, Guo, Yin, Chen, Xiao, Deng (bib49) 2020; 96
Page, McKenzie, Bossuyt, Boutron, Hoffmann, Mulrow, Shamseer, Tetzlaff, Akl, Brennan, Chou, Glanville, Grimshaw, Hróbjartsson, Lalu, Li, Loder, Mayo-Wilson, McDonald, McGuinness, Stewart, Thomas, Tricco, Welch, Whiting, Moher (bib31) 2021; 18
Chirumbolo, Callea, Urbini (bib4) 2021; 18
Christensen (10.1016/j.jpsychires.2021.09.054_bib5) 2011; 29
Han (10.1016/j.jpsychires.2021.09.054_bib11) 2020; 9
González (10.1016/j.jpsychires.2021.09.054_bib10) 2021
Sepúlveda-Loyola (10.1016/j.jpsychires.2021.09.054_bib37) 2020; 24
Mueller (10.1016/j.jpsychires.2021.09.054_bib25) 2020; 12
Page (10.1016/j.jpsychires.2021.09.054_bib31) 2021; 18
Ragab (10.1016/j.jpsychires.2021.09.054_bib34) 2020; 11
Ng (10.1016/j.jpsychires.2021.09.054_bib29) 2018
Szlamka (10.1016/j.jpsychires.2021.09.054_bib40) 2021; 12
Muñoz-Fontela (10.1016/j.jpsychires.2021.09.054_bib26) 2020; 586
Fajgenbaum (10.1016/j.jpsychires.2021.09.054_bib8) 2020; 383
Nasserie (10.1016/j.jpsychires.2021.09.054_bib28) 2021; 4
Wells (10.1016/j.jpsychires.2021.09.054_bib46) 2000
Xiong (10.1016/j.jpsychires.2021.09.054_bib48) 2020; 277
Chirumbolo (10.1016/j.jpsychires.2021.09.054_bib4) 2021; 18
Sinanović (10.1016/j.jpsychires.2021.09.054_bib39) 2021; 33
(10.1016/j.jpsychires.2021.09.054_bib14) 2017; 390
Lu (10.1016/j.jpsychires.2021.09.054_bib20) 2017; 12
Lee (10.1016/j.jpsychires.2021.09.054_bib16) 2021; 290
Morin (10.1016/j.jpsychires.2021.09.054_bib24) 2021; 325
Mazza (10.1016/j.jpsychires.2021.09.054_bib22) 2020; 89
Loades (10.1016/j.jpsychires.2021.09.054_bib19) 2020; 59
Liu (10.1016/j.jpsychires.2021.09.054_bib18) 2021; 137
Cao (10.1016/j.jpsychires.2021.09.054_bib3) 2020; 287
Lee (10.1016/j.jpsychires.2021.09.054_bib15) 2019; 10
Wang (10.1016/j.jpsychires.2021.09.054_bib45) 2021; 11
Ettman (10.1016/j.jpsychires.2021.09.054_bib7) 2020; 3
Mattioli (10.1016/j.jpsychires.2021.09.054_bib21) 2021
Taquet (10.1016/j.jpsychires.2021.09.054_bib41) 2021; 8
Vanderlind (10.1016/j.jpsychires.2021.09.054_bib44) 2021; 34
Zubair (10.1016/j.jpsychires.2021.09.054_bib50) 2020; 77
Zeng (10.1016/j.jpsychires.2021.09.054_bib49) 2020; 96
(10.1016/j.jpsychires.2021.09.054_bib1) 2021
Ng (10.1016/j.jpsychires.2021.09.054_bib30) 2020; 10
Pieh (10.1016/j.jpsychires.2021.09.054_bib33) 2020; 136
Rass (10.1016/j.jpsychires.2021.09.054_bib35) 2021
Mazza (10.1016/j.jpsychires.2021.09.054_bib23) 2021; 94
Nalbandian (10.1016/j.jpsychires.2021.09.054_bib27) 2021; 27
Shanbehzadeh (10.1016/j.jpsychires.2021.09.054_bib38) 2021; 147
Berk (10.1016/j.jpsychires.2021.09.054_bib2) 2013; 11
Huang (10.1016/j.jpsychires.2021.09.054_bib13) 2021
Daher (10.1016/j.jpsychires.2021.09.054_bib6) 2021; 18
Frontera (10.1016/j.jpsychires.2021.09.054_bib9) 2021; 426
Rosenblat (10.1016/j.jpsychires.2021.09.054_bib36) 2014; 53
van den Borst (10.1016/j.jpsychires.2021.09.054_bib43) 2020
Ho (10.1016/j.jpsychires.2021.09.054_bib12) 2020; 49
Liu (10.1016/j.jpsychires.2021.09.054_bib17) 2012
Troyer (10.1016/j.jpsychires.2021.09.054_bib42) 2020; 87
Parker (10.1016/j.jpsychires.2021.09.054_bib32) 2010; 22
References_xml – year: 2021
  ident: bib1
  article-title: Rapid Guideline: Managing the Long-Term Effects of COVID-19
– volume: 22
  start-page: 429
  year: 2010
  end-page: 436
  ident: bib32
  article-title: Gender differences in depression
  publication-title: Int. Rev. Psychiatr.
– volume: 94
  start-page: 138
  year: 2021
  end-page: 147
  ident: bib23
  article-title: Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up
  publication-title: Brain Behav. Immun.
– volume: 77
  start-page: 1018
  year: 2020
  end-page: 1027
  ident: bib50
  article-title: Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review
  publication-title: JAMA Neurol
– volume: 586
  start-page: 509
  year: 2020
  end-page: 515
  ident: bib26
  article-title: Animal models for COVID-19
  publication-title: Nature
– volume: 277
  start-page: 55
  year: 2020
  end-page: 64
  ident: bib48
  article-title: Impact of COVID-19 pandemic on mental health in the general population: a systematic review
  publication-title: J. Affect. Disord.
– year: 2021
  ident: bib13
  article-title: COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic
– volume: 12
  year: 2017
  ident: bib20
  article-title: Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depression
  publication-title: PLoS One
– volume: 290
  start-page: 364
  year: 2021
  end-page: 377
  ident: bib16
  article-title: Government response moderates the mental health impact of COVID-19: a systematic review and meta-analysis of depression outcomes across countries
  publication-title: J. Affect. Disord.
– year: 2000
  ident: bib46
  article-title: The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta- Analysis
– volume: 9
  start-page: 1123
  year: 2020
  end-page: 1130
  ident: bib11
  article-title: Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
  publication-title: Emerg. Microb. Infect.
– volume: 33
  start-page: S309
  year: 2021
  end-page: S317
  ident: bib39
  article-title: LONG-TERM neuropsychiatric consequences OF SARS-COV infections
  publication-title: Psychiatr. Danub.
– volume: 12
  start-page: 655211
  year: 2021
  ident: bib40
  article-title: Mental health support in the time of crisis: are we prepared? Experiences with the COVID-19 counselling programme in Hungary
  publication-title: Front. Psychiatr.
– volume: 59
  start-page: 1218
  year: 2020
  end-page: 1239
  ident: bib19
  article-title: Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and Adolescents in the context of COVID-19
  publication-title: J. Am. Acad. Child Adolesc. Psychiatry
– volume: 4
  year: 2021
  ident: bib28
  article-title: Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review
  publication-title: JAMA Netw Open
– volume: 383
  start-page: 2255
  year: 2020
  end-page: 2273
  ident: bib8
  article-title: Cytokine storm
  publication-title: N. Engl. J. Med.
– volume: 53
  start-page: 23
  year: 2014
  end-page: 34
  ident: bib36
  article-title: Inflamed moods: a review of the interactions between inflammation and mood disorders
  publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry
– volume: 18
  year: 2021
  ident: bib6
  article-title: Six months follow-up of patients with invasive mechanical ventilation due to COVID-19 related ARDS
  publication-title: Int. J. Environ. Res. Publ. Health
– volume: 87
  start-page: 34
  year: 2020
  end-page: 39
  ident: bib42
  article-title: Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms
  publication-title: Brain Behav. Immun.
– year: 2021
  ident: bib35
  article-title: Neurological outcome and quality of life 3 months after COVID-19: a prospective observational cohort study
  publication-title: Eur. J. Neurol.
– year: 2021
  ident: bib47
– volume: 137
  start-page: 542
  year: 2021
  end-page: 553
  ident: bib18
  article-title: Mental health outcomes of coronavirus infection survivors: a rapid meta-analysis
  publication-title: J. Psychiatr. Res.
– volume: 147
  start-page: 110525
  year: 2021
  ident: bib38
  article-title: Physical and mental health complications post-COVID-19: scoping review
  publication-title: J. Psychosom. Res.
– volume: 11
  start-page: 6481
  year: 2021
  ident: bib45
  article-title: A chain mediation model on COVID-19 symptoms and mental health outcomes in Americans, Asians and Europeans
  publication-title: Sci. Rep.
– volume: 8
  start-page: 416
  year: 2021
  end-page: 427
  ident: bib41
  article-title: 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records
  publication-title: Lancet Psychiatry
– year: 2021
  ident: bib21
  article-title: Neurological and cognitive sequelae of Covid-19: a four month follow-up
  publication-title: J. Neurol.
– volume: 10
  start-page: 21
  year: 2020
  ident: bib30
  article-title: Mindfulness improves inflammatory biomarker levels in older adults with mild cognitive impairment: a randomized controlled trial
  publication-title: Transl. Psychiatry
– volume: 3
  year: 2020
  ident: bib7
  article-title: Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic
  publication-title: JAMA Netw Open
– volume: 49
  start-page: 155
  year: 2020
  end-page: 160
  ident: bib12
  article-title: Mental health strategies to combat the psychological impact of Coronavirus disease 2019 (COVID-19) beyond paranoia and panic
  publication-title: Ann. Acad. Med. Singapore
– volume: 325
  start-page: 1525
  year: 2021
  end-page: 1534
  ident: bib24
  article-title: Four-month clinical status of a cohort of patients after hospitalization for COVID-19
  publication-title: J. Am. Med. Assoc.
– volume: 29
  start-page: 80
  year: 2011
  end-page: 84
  ident: bib5
  article-title: Case-finding and risk-group screening for depression in primary care
  publication-title: Scand. J. Prim. Health Care
– volume: 390
  start-page: 1211
  year: 2017
  end-page: 1259
  ident: bib14
  article-title: Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
  publication-title: Lancet
– volume: 18
  year: 2021
  ident: bib4
  article-title: The effect of job insecurity and life uncertainty on Everyday consumptions and broader life projects during COVID-19 pandemic
  publication-title: Int. J. Environ. Res. Publ. Health
– volume: 12
  start-page: 9959
  year: 2020
  end-page: 9981
  ident: bib25
  article-title: Why does COVID-19 disproportionately affect older people?
  publication-title: Aging
– year: 2020
  ident: bib43
  article-title: Comprehensive health assessment three months after recovery from acute COVID-19
  publication-title: Clin. Infect. Dis.
– year: 2018
  ident: bib29
  article-title: IL-1β, IL-6, TNF- α and CRP in elderly patients with depression or Alzheimer's disease: systematic review and meta-analysis
  publication-title: Sci. Rep.
– volume: 136
  start-page: 110186
  year: 2020
  ident: bib33
  article-title: The effect of age, gender, income, work, and physical activity on mental health during coronavirus disease (COVID-19) lockdown in Austria
  publication-title: J. Psychosom. Res.
– volume: 18
  year: 2021
  ident: bib31
  article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
  publication-title: PLoS Med.
– volume: 27
  start-page: 601
  year: 2021
  end-page: 615
  ident: bib27
  article-title: Post-acute COVID-19 syndrome
  publication-title: Nat. Med.
– volume: 34
  start-page: 420
  year: 2021
  end-page: 433
  ident: bib44
  article-title: A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment
  publication-title: Curr. Opin. Psychiatr.
– volume: 89
  start-page: 594
  year: 2020
  end-page: 600
  ident: bib22
  article-title: Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors
  publication-title: Brain Behav. Immun.
– volume: 287
  start-page: 112934
  year: 2020
  ident: bib3
  article-title: The psychological impact of the COVID-19 epidemic on college students in China
  publication-title: Psychiatr. Res.
– volume: 426
  start-page: 117486
  year: 2021
  ident: bib9
  article-title: A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications
  publication-title: J. Neurol. Sci.
– volume: 10
  start-page: 1696
  year: 2019
  ident: bib15
  article-title: The role of inflammation in depression and fatigue
  publication-title: Front. Immunol.
– volume: 24
  start-page: 938
  year: 2020
  end-page: 947
  ident: bib37
  article-title: Impact of social isolation due to COVID-19 on health in older people: mental and physical effects and recommendations
  publication-title: J. Nutr. Health Aging
– volume: 96
  start-page: 467
  year: 2020
  end-page: 474
  ident: bib49
  article-title: Association of inflammatory markers with the severity of COVID-19: a meta-analysis
  publication-title: Int. J. Infect. Dis.
– year: 2021
  ident: bib10
  article-title: Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort
  publication-title: Chest
– year: 2012
  ident: bib17
  article-title: Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression
  publication-title: J. Affect. Disord.
– volume: 11
  start-page: 200
  year: 2013
  ident: bib2
  article-title: So depression is an inflammatory disease, but where does the inflammation come from?
  publication-title: BMC Med.
– volume: 11
  start-page: 1446
  year: 2020
  ident: bib34
  article-title: The COVID-19 cytokine storm; what we know so far
  publication-title: Front. Immunol.
– year: 2018
  ident: 10.1016/j.jpsychires.2021.09.054_bib29
  article-title: IL-1β, IL-6, TNF- α and CRP in elderly patients with depression or Alzheimer's disease: systematic review and meta-analysis
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-30487-6
– volume: 22
  start-page: 429
  year: 2010
  ident: 10.1016/j.jpsychires.2021.09.054_bib32
  article-title: Gender differences in depression
  publication-title: Int. Rev. Psychiatr.
  doi: 10.3109/09540261.2010.492391
– volume: 18
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib4
  article-title: The effect of job insecurity and life uncertainty on Everyday consumptions and broader life projects during COVID-19 pandemic
  publication-title: Int. J. Environ. Res. Publ. Health
  doi: 10.3390/ijerph18105363
– volume: 94
  start-page: 138
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib23
  article-title: Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2021.02.021
– volume: 586
  start-page: 509
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib26
  article-title: Animal models for COVID-19
  publication-title: Nature
  doi: 10.1038/s41586-020-2787-6
– volume: 27
  start-page: 601
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib27
  article-title: Post-acute COVID-19 syndrome
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01283-z
– volume: 77
  start-page: 1018
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib50
  article-title: Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2020.2065
– volume: 11
  start-page: 200
  year: 2013
  ident: 10.1016/j.jpsychires.2021.09.054_bib2
  article-title: So depression is an inflammatory disease, but where does the inflammation come from?
  publication-title: BMC Med.
  doi: 10.1186/1741-7015-11-200
– volume: 9
  start-page: 1123
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib11
  article-title: Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
  publication-title: Emerg. Microb. Infect.
  doi: 10.1080/22221751.2020.1770129
– volume: 390
  start-page: 1211
  year: 2017
  ident: 10.1016/j.jpsychires.2021.09.054_bib14
  article-title: Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)32154-2
– volume: 147
  start-page: 110525
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib38
  article-title: Physical and mental health complications post-COVID-19: scoping review
  publication-title: J. Psychosom. Res.
  doi: 10.1016/j.jpsychores.2021.110525
– year: 2000
  ident: 10.1016/j.jpsychires.2021.09.054_bib46
– volume: 87
  start-page: 34
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib42
  article-title: Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2020.04.027
– volume: 12
  start-page: 9959
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib25
  article-title: Why does COVID-19 disproportionately affect older people?
  publication-title: Aging
  doi: 10.18632/aging.103344
– volume: 18
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib31
  article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1003583
– volume: 8
  start-page: 416
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib41
  article-title: 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(21)00084-5
– volume: 10
  start-page: 21
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib30
  article-title: Mindfulness improves inflammatory biomarker levels in older adults with mild cognitive impairment: a randomized controlled trial
  publication-title: Transl. Psychiatry
  doi: 10.1038/s41398-020-0696-y
– volume: 29
  start-page: 80
  year: 2011
  ident: 10.1016/j.jpsychires.2021.09.054_bib5
  article-title: Case-finding and risk-group screening for depression in primary care
  publication-title: Scand. J. Prim. Health Care
  doi: 10.3109/02813432.2011.554009
– volume: 325
  start-page: 1525
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib24
  article-title: Four-month clinical status of a cohort of patients after hospitalization for COVID-19
  publication-title: J. Am. Med. Assoc.
  doi: 10.1001/jama.2021.3331
– volume: 33
  start-page: S309
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib39
  article-title: LONG-TERM neuropsychiatric consequences OF SARS-COV infections
  publication-title: Psychiatr. Danub.
– volume: 12
  start-page: 655211
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib40
  article-title: Mental health support in the time of crisis: are we prepared? Experiences with the COVID-19 counselling programme in Hungary
  publication-title: Front. Psychiatr.
  doi: 10.3389/fpsyt.2021.655211
– volume: 137
  start-page: 542
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib18
  article-title: Mental health outcomes of coronavirus infection survivors: a rapid meta-analysis
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2020.10.015
– year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib10
  article-title: Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort
  publication-title: Chest
  doi: 10.1016/j.chest.2021.02.062
– volume: 277
  start-page: 55
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib48
  article-title: Impact of COVID-19 pandemic on mental health in the general population: a systematic review
  publication-title: J. Affect. Disord.
  doi: 10.1016/j.jad.2020.08.001
– volume: 426
  start-page: 117486
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib9
  article-title: A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2021.117486
– volume: 59
  start-page: 1218
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib19
  article-title: Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and Adolescents in the context of COVID-19
  publication-title: J. Am. Acad. Child Adolesc. Psychiatry
  doi: 10.1016/j.jaac.2020.05.009
– volume: 96
  start-page: 467
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib49
  article-title: Association of inflammatory markers with the severity of COVID-19: a meta-analysis
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2020.05.055
– year: 2012
  ident: 10.1016/j.jpsychires.2021.09.054_bib17
  article-title: Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression
  publication-title: J. Affect. Disord.
  doi: 10.1016/j.jad.2011.08.003
– volume: 49
  start-page: 155
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib12
  article-title: Mental health strategies to combat the psychological impact of Coronavirus disease 2019 (COVID-19) beyond paranoia and panic
  publication-title: Ann. Acad. Med. Singapore
  doi: 10.47102/annals-acadmedsg.202043
– volume: 290
  start-page: 364
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib16
  article-title: Government response moderates the mental health impact of COVID-19: a systematic review and meta-analysis of depression outcomes across countries
  publication-title: J. Affect. Disord.
  doi: 10.1016/j.jad.2021.04.050
– volume: 34
  start-page: 420
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib44
  article-title: A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment
  publication-title: Curr. Opin. Psychiatr.
  doi: 10.1097/YCO.0000000000000713
– volume: 11
  start-page: 1446
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib34
  article-title: The COVID-19 cytokine storm; what we know so far
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.01446
– volume: 18
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib6
  article-title: Six months follow-up of patients with invasive mechanical ventilation due to COVID-19 related ARDS
  publication-title: Int. J. Environ. Res. Publ. Health
  doi: 10.3390/ijerph18115861
– volume: 12
  year: 2017
  ident: 10.1016/j.jpsychires.2021.09.054_bib20
  article-title: Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depression
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0186700
– volume: 53
  start-page: 23
  year: 2014
  ident: 10.1016/j.jpsychires.2021.09.054_bib36
  article-title: Inflamed moods: a review of the interactions between inflammation and mood disorders
  publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry
  doi: 10.1016/j.pnpbp.2014.01.013
– volume: 3
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib7
  article-title: Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2020.19686
– volume: 11
  start-page: 6481
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib45
  article-title: A chain mediation model on COVID-19 symptoms and mental health outcomes in Americans, Asians and Europeans
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-85943-7
– volume: 287
  start-page: 112934
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib3
  article-title: The psychological impact of the COVID-19 epidemic on college students in China
  publication-title: Psychiatr. Res.
  doi: 10.1016/j.psychres.2020.112934
– volume: 24
  start-page: 938
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib37
  article-title: Impact of social isolation due to COVID-19 on health in older people: mental and physical effects and recommendations
  publication-title: J. Nutr. Health Aging
  doi: 10.1007/s12603-020-1500-7
– year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib35
  article-title: Neurological outcome and quality of life 3 months after COVID-19: a prospective observational cohort study
  publication-title: Eur. J. Neurol.
  doi: 10.1111/ene.14803
– volume: 10
  start-page: 1696
  year: 2019
  ident: 10.1016/j.jpsychires.2021.09.054_bib15
  article-title: The role of inflammation in depression and fatigue
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01696
– volume: 4
  year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib28
  article-title: Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2021.11417
– volume: 136
  start-page: 110186
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib33
  article-title: The effect of age, gender, income, work, and physical activity on mental health during coronavirus disease (COVID-19) lockdown in Austria
  publication-title: J. Psychosom. Res.
  doi: 10.1016/j.jpsychores.2020.110186
– volume: 383
  start-page: 2255
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib8
  article-title: Cytokine storm
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra2026131
– year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib13
– year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib21
  article-title: Neurological and cognitive sequelae of Covid-19: a four month follow-up
  publication-title: J. Neurol.
  doi: 10.1007/s00415-021-10579-6
– volume: 89
  start-page: 594
  year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib22
  article-title: Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2020.07.037
– year: 2020
  ident: 10.1016/j.jpsychires.2021.09.054_bib43
  article-title: Comprehensive health assessment three months after recovery from acute COVID-19
  publication-title: Clin. Infect. Dis.
– year: 2021
  ident: 10.1016/j.jpsychires.2021.09.054_bib1
SSID ssj0007214
Score 2.6953669
SecondaryResourceType review_article
Snippet Following recovery from COVID-19, an increasing proportion of individuals have reported the persistence and/or new onset of symptoms which collectively have...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 129
SubjectTerms COVID-19
COVID-19 - complications
Depression
Depression - epidemiology
Depression - etiology
Humans
Population health
Post-Acute COVID-19 Syndrome
Post-acute sequelae of COVID-19
Post-COVID-19 syndrome
Prospective Studies
SARS-CoV-2
Title Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
URI https://www.clinicalkey.com/#!/content/1-s2.0-S002239562100594X
https://dx.doi.org/10.1016/j.jpsychires.2021.09.054
https://www.ncbi.nlm.nih.gov/pubmed/34619491
https://www.proquest.com/docview/2580691696
https://pubmed.ncbi.nlm.nih.gov/PMC8482840
Volume 144
WOSCitedRecordID wos000707671500017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: ScienceDirect
  customDbUrl:
  eissn: 1879-1379
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0007214
  issn: 0022-3956
  databaseCode: AIEXJ
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6DqG9IO6Uy2Qk3lCqXJw4hqeqbGJIW_dQQd8i23FES-VWvWz7M_xXjuPETTsmChIvUZXabu3zxT4-_s4XhN4RP885k5EnEyE9osLcY-C5egRWq7AESSzKl03Qi4t0NGKXrdbPOhfmakq1Tm9u2Py_mhrugbFN6uxfmNs1CjfgMxgdrmB2uO5l-IFeKksbLxaWJ10eojvKa0ltnM-WK68_-Hr2yQuYky2waeq74s7XdziwjihdFmxExcz5jdJ8nXvmMF_ZrJLBdGyWYEcAWtu0bMW15u_Pu9-6zrdf_igzbsq4rBGOdEH_vhI2XHuqpiYa04xYhEGD_dHIIGBWUNzNwoQ05tGgCoPYJTmwujC3ZnsbeJh0J7bD0KGu-b1SuNZKU28LbO8sfI6OWDPdJtmmpcy0lPksg5YO0GFIY5a20WHv7GT0xS31sH0mTo4eOlRRxSyB8Pf_6i7_5_b-Zpem2_B7hg_Rg8reuGeB9gi1lH6M7p9XlIwn6LLEGwaTYYc3PCvwBm94rPEW3nCNtw-4hzdowxZtT9Hw9GTY_-xVr-nwZBwlK68gYW78xCDhqaKSFIJKKYK0EMSnSvEklwktJJhUSlr4cShFyPMiVzSKCJHRM9TWM61eICxicB9DmfA8oiSnkhMiuJH8p0IoFtIOovXYZbKSsDdvUplmf7JgBwWu5tzKuOxRh9Xmyeo0ZVhYM0DfHnU_urqVK2td1D1rv63RkMFsb47wuFazNRSKUz-BHR1LOui5RYfrT0RMRJIFMEpbuHEFjJL89jd6_L1UlE9JCm6q__IfRukVOto8469Re7VYqzfonrxajZeLY3RAR-lx9dj8ApiD8nI
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Onset+and+frequency+of+depression+in+post-COVID-19+syndrome%3A+A+systematic+review&rft.jtitle=Journal+of+psychiatric+research&rft.au=Renaud-Charest%2C+Olivier&rft.au=Lui%2C+Leanna+M.W.&rft.au=Eskander%2C+Sherry&rft.au=Ceban%2C+Felicia&rft.date=2021-12-01&rft.issn=0022-3956&rft.volume=144&rft.spage=129&rft.epage=137&rft_id=info:doi/10.1016%2Fj.jpsychires.2021.09.054&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jpsychires_2021_09_054
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3956&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3956&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3956&client=summon